Pioneering seaweed harvest takes place in North Sea
The harvest provides valuable insights to researchers looking into how seaweed farms could remove carbon from the atmosphere, contributing to climate resilience, and how to scale the cultivation of seaweed globally. Seaweed farms could also promote biodiversity and reduce agricultural pressure on land.
'The inaugural harvest of North Sea Farm 1 is a significant moment,' said Eva Faict, Amazon Netherlands and Belgium country manager. 'Together with North Sea Farmers, we have proven that cultivated seaweed farming among offshore wind turbines is a viable commercial concept.'
By locating the farm between offshore wind turbines—a world first for a commercial-scale seaweed farm—North Sea Farmers found a way of securing physical space for the farm away from maritime traffic.
'Through ongoing scientific research, we aim to demonstrate whether farms like this can have a positive long-term impact on both biodiversity and climate change mitigation,' said Eef Brouwers, Managing Director of North Sea Farmers. 'At the same time, we're proving that seaweed production within an existing offshore infrastructure is possible at a commercial scale.'
The harvesting process at North Sea Farm 1—spanning five hectares of the 'Hollandse Kust Zuid' wind farm—involves the use of a vessel carefully navigating between wind turbines, collecting seaweed from nets anchored to the seabed.
Plymouth Marine Laboratory , Deltares and Silvestrum Climate Associates have been monitoring the farm using satellite data, as well as site visits, to understand upper scaling limits for future projects.
Professor Ana M Queirós, Plymouth Marine Laboratory's Climate Change Lead, said: 'We're very excited to understand the effects of the seaweed farm on the immediate and surrounding marine environment. Our analysis will follow the carbon from the seawater into the seaweed and the environment, and any effects on biodiversity.
'It's vital projects like this are underpinned with rigorous scientific evidence, particularly given the urgency of the climate and biodiversity crisis and the need to find scalable mitigation measures that produce genuinely beneficial and sustainable outcomes.'
Visuels de la récolte pour la presse : https://ap.lc/oeNZj
Photo: https://mma.prnewswire.com/media/2729896/AMAZON_NorthSeaSeaweed.jpg
View original content:https://www.prnewswire.co.uk/news-releases/pioneering-seaweed-harvest-takes-place-in-north-sea-302503802.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
7 hours ago
- Malaysian Reserve
Pioneering seaweed harvest takes place in North Sea
THE HAGUE, Netherlands , July 14, 2025 /PRNewswire/ — Seaweed farmers have made the first-ever harvest at North Sea Farm 1, the world's first commercial-scale seaweed farm located in a field of wind turbines off the coast of Scheveningen in the Netherlands. The farm was created by North Sea Farmers with €2 million funding from Amazon's Right Now Climate Fund. The harvest provides valuable insights to researchers looking into how seaweed farms could remove carbon from the atmosphere, contributing to climate resilience, and how to scale the cultivation of seaweed globally. Seaweed farms could also promote biodiversity and reduce agricultural pressure on land. 'The inaugural harvest of North Sea Farm 1 is a significant moment,' said Eva Faict, Amazon Netherlands and Belgium country manager. 'Together with North Sea Farmers, we have proven that cultivated seaweed farming among offshore wind turbines is a viable commercial concept.' By locating the farm between offshore wind turbines—a world first for a commercial-scale seaweed farm—North Sea Farmers found a way of securing physical space for the farm away from maritime traffic. 'Through ongoing scientific research, we aim to demonstrate whether farms like this can have a positive long-term impact on both biodiversity and climate change mitigation,' said Eef Brouwers, Managing Director of North Sea Farmers. 'At the same time, we're proving that seaweed production within an existing offshore infrastructure is possible at a commercial scale.' The harvesting process at North Sea Farm 1—spanning five hectares of the 'Hollandse Kust Zuid' wind farm—involves the use of a vessel carefully navigating between wind turbines, collecting seaweed from nets anchored to the seabed. Plymouth Marine Laboratory , Deltares and Silvestrum Climate Associates have been monitoring the farm using satellite data, as well as site visits, to understand upper scaling limits for future projects. Professor Ana M Queirós, Plymouth Marine Laboratory's Climate Change Lead, said: 'We're very excited to understand the effects of the seaweed farm on the immediate and surrounding marine environment. Our analysis will follow the carbon from the seawater into the seaweed and the environment, and any effects on biodiversity. 'It's vital projects like this are underpinned with rigorous scientific evidence, particularly given the urgency of the climate and biodiversity crisis and the need to find scalable mitigation measures that produce genuinely beneficial and sustainable outcomes.' Visuels de la récolte pour la presse : Photo: View original content:
Malaysian Reserve
2 days ago
- Malaysian Reserve
June in Review: 14 Top Health Press Releases
A roundup of the most newsworthy healthcare press releases from PR Newswire, including a nasal spray for sleep apnea, a landmark study in clinical cancer research and a new approach to increasing longevity. NEW YORK, July 11, 2025 /PRNewswire/ — With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the month's most popular releases and newsworthy trends, here's a recap of some of the past month's most read- and engaged-with stories. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download. Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketingIn support of transitioning patients from knock-off versions to authentic versions of Wegovy®, Novo Nordisk began collaborating with telehealth companies. Over one month into the collaboration, Hims & Hers Health, Inc. has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization' and are disseminating deceptive marketing that put patient safety at risk. Big4Bio and BYTE51 Announce Partnership at 2025 BIO International Convention to Make Life Sciences Intelligence Accessible to All BYTE51 provides powerful tools for exploring privately held biotech companies, allowing users to filter by scientific indications, mechanisms of action, funding stages, location, capital raised, clinical progress, investors, and partners. This empowers VCs, business developers, and startup executives alike to make faster, smarter, and more strategic decisions, all of which can benefit the diverse Big4Bio audience. Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk'VERVE-102 has the potential to be the first in vivo gene editing therapy for broad patient populations and could shift the treatment paradigm for cardiovascular disease from chronic care to one-and-done treatment,' said Ruth Gimeno, Lilly group vice president, Diabetes and Metabolic Research and Development. Mark Cuban Cost Plus Drug Company, PBC and 9amHealth Join Forces to Expand Access to Affordable Obesity Care Employees will now have access to low-cost, high-quality medications through Cost Plus Drugs, alongside 9amHealth's expert Care Team of Obesity Medicine physicians, endocrinologists, and cardiometabolic specialists—all available without long waits or costly appointments. Klotho Neuroscience, Inc. Announces an Approach To Increase Longevity and Healthy Life Span – Replace a Silenced Gene Called Alpha-Klotho ('α- KLOTHO') Recent clinical and pre-clinical studies and analysis indicates the potential to increase lifespan and reduce age-associated degeneration in multiple organ systems has be realized with a focus on the human gene called Klotho. AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology 'By advancing CPTX2309 and utilizing Capstan's novel platform technology, AbbVie and Capstan aim to transform the care of those living with autoimmune diseases by developing treatments that have the potential to reset the immune system,' said Roopal Thakkar, M.D., executive vice president, research and development and chief scientific officer, AbbVie. Neuspera Medical Receives FDA Approval for First Integrated Sacral Neuromodulation (iSNM) System for Urinary Urge Incontinence 'For too long, patients have had to weigh the benefits of SNM therapy against real concerns about complications related to implanted batteries and the need for surgeries to replace it. Neuspera's integrated system provides symptom relief without these additional burdens,' said Dr. Howard Goldman, vice-chairman of Urology at the Cleveland Clinic. Shasqi Publishes Landmark Study in Clinical Cancer Research: First-in-Human Use of Click Chemistry Unlocks New Opportunities for Targeted Cancer Therapies Shasqi's Click Activated Protodrugs Against Cancer (CAPAC®) platform is a pre-targeting technology composed of a tumor binding agent and a protodrug. Administered sequentially, these components are designed to only click with each other via a click chemistry reaction occurring directly at the tumor site. This releases high concentrations of cancer drugs at the tumor while sparing healthy tissues. Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy This transaction builds on a co-development agreement Illumina established with SomaLogic in December 2021 to bring the SomaScan® Proteomics Assay onto Illumina's high-throughput next-generation-sequencing (NGS) platforms. Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™ The Processor is the first in bone conduction to enable Bluetooth® LE Audio* and Auracast™ broadcast audio streaming capabilities. As more venues adopt Auracast technology, Baha 7 Sound Processor recipients can access audio streams in places like theaters, concert halls, lecture halls and airports, through an LE Audio-enabled smartphone. Novogene Certified for Olink® Services Across Multiple Labs; Expands Proteomics Portfolio with Olink® Reveal 'With Olink® Reveal offering deep insights into inflammatory biology, we empower researchers to accelerate biomarker discovery, translational research, and precision medicine. This recognition further enhances Novogene's leadership in comprehensive multi-omics solutions,' said Justin Lee, Novogene VP of Global Marketing. Mosanna Therapeutics Launches with $80 Million to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea Mosanna is pioneering a pharmaceutical solution for sleep apnea patients with MOS118, a nasal spray administered at bedtime that helps restore the body's natural airway reflex. Research has shown that, for reasons yet unknown, the natural airway reflex in OSA patients exhibits decreased activity during sleep resulting in loss of airway patency and apnea. Grady Launches Emergency Medical Helicopter in Partnership with Air Methods This cutting-edge air ambulance will be staffed entirely by Grady medical personnel – highly trained nurses, paramedics, and critical care specialists – while experienced pilots from Air Methods will operate the aircraft. The partnership brings together top-tier medical care and aviation expertise to deliver life-saving interventions to patients faster than ever before. Visby Medical™ Raises up to $65 Million in New Financing Round to Accelerate Launch of Groundbreaking At-Home Sexually Transmitted Infections (STI) Test 'Visby Medical has delivered the first and only laboratory-grade STI testing solution that can be made directly accessible to individuals. We were eager to invest in Visby ahead of their FDA clearance, knowing this would represent a breakthrough moment for the diagnostics industry,' said Isaac Ro, Catalio Capital Management Partner. For more news like this, check out all of the latest health-related releases from PR Newswire. Trending Topics Among the health news that was distributed in June, the PR Newswire team was able spot several larger stories that highlight the trends shaping the industry. Men's Mental Health: Men's Mental Health Month aims to break the stigma and explore the factors that play into to the often less talked about issue. Studies released in June point looked into several contributing factors. According to Postpartum Support International, at least one in ten fathers experience postpartum depression during the perinatal period with as many as 50% of fathers suffering at the same time as their partners. On the financial side of things, Beyond Finance revealed financial distress is fueling a silent mental health crisis among men, driven by secrecy, shame and isolation. Men have reported feeling frustrated, anxious, overwhelmed and embarrassed because of their financial situation — yet nearly a quarter (22%) don't feel comfortable seeking out financial advice from anyone. Sleep Health: The Associated Professional Sleep Societies (APSS) hosted its annual meeting, SLEEP 2025, in Seattle from June 8-11. The event showcased several advances shaping the future of sleep medicine. Researchers from Huxley Medical shared data highlighting the capabilities of the SANSA home sleep apnea test. Another study, this one from Rest and SleepScore Labs, showed significant perceived improvements in sleep comfort, temperature regulation and overall sleep quality when using Rest's Evercool® products like pillowcases and sheets. Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most. Helping Journalists Stay Up to Date on Industry News These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists. Once they're signed up, reporters, bloggers, and freelancers have access to the following free features: Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more. Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story. Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles. Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more. About PR Newswire PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world. For questions, contact the team at
Malaysian Reserve
3 days ago
- Malaysian Reserve
Chinese Orthodontic Expertise Featured in JAO's Coverage of DGAO 2024
——Professor Gang Shen's Mandibular Repositioning Protocol Highlighted in JAO's Summary of Leading Presentations at the German Aligner Congress COLOGNE, Germany, July 11, 2025 /PRNewswire/ — The Journal of Aligner Orthodontics (JAO), a leading international publication in the field, recently published a comprehensive summary of keynote presentations delivered at the 8th Congress of the German Association for Aligner Orthodontics (DGAO), held in Cologne in November 2024. Among the featured speakers was Professor Gang Shen, Chief R&D Scientist of Smartee Denti-Technology and Executive President of Taikang Bybo Dental Group, whose clinical approach to mandibular repositioning therapy drew particular attention for its structured methodology and non-surgical success in treating Class II skeletal malocclusions. According to JAO's summary, Professor Shen opened his keynote by introducing his diagnostic concept of 'three-depth malocclusion', a complex condition defined by: retrusive mandible, increased facial convexity, excessive overjet, deep overbite, a pronounced curve of Spee, and a Class II molar relationship. JAO highlighted the clinical challenge of treating such cases in adult patients, where orthognathic surgery is often clinically indicated but often declined by patients, and conventional treatments like maxillary distalization or premolar extractions have limited applicability. To overcome these limitations, Professor Shen proposed an orthopedic treatment approach using Smartee's S8-SGTB clear aligner system. The protocol is a two-phase treatment strategy, beginning with mandibular repositioning, achieved through the combination of vertical bite blocks and guided anterior mandibular advancement using the S8-SGTB appliance. In the subsequent phase, once the mandible has been repositioned, aligners are used to guide incisor intrusion and molar extrusion, optimizing occlusal relationships. The mandibular advancement also promotes adaptive bone remodeling in the posterior region of The vertical tooth movements are controlled via the aligner system, not directly caused by mandibular advancement itself. As emphasized in the JAO article, Professor Shen underscored that temporomandibular joint (TMJ) remodeling remains biologically viable even in adults, making effective repositioning feasible beyond adolescence. He also outlined a four-step simulation protocol to determine and record the optimal mandibular advancement position: 1. Complete an intraoral scan to record the patient's dentition anatomical structures.2. Perform a repositioning simulation to define the new jaw position3. Use wax registration to secure the position4. Take a posterior occlusal scan to digitally capture the final mandibular postureNote: The construction bite should maintain a 5 mm posterior clearance. The documented success of Smartee's GS system, with over 100,000 clinical applications to date, further validates its scalability, precision, and non-invasive treatment potential. To learn more about Smartee's Mandibular Repositioning Technology and explore case examples, visit: Photo – View original content:
